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Recently, a non-coding RNA expressed from a human
pseudogene was reported to regulate the corresponding
protein-coding mRNA by acting as a decoy for microRNAs
(miRNAs) that bind to common sites in the 30 untranslated
regions (UTRs). It was proposed that competing for
miRNAs might be a general activity of pseudogenes. This
study raises questions about the potential ability of thou-
sands of non-coding transcripts to interact with miRNAs
and influence the expression ofmiRNA target genes. Three
years ago, artificial miRNA decoys termed ‘miRNA
sponges’ were introduced as a means to create loss-of-
function phenotypes for miRNA families in cell culture and
in virally infected tissue and transgenic animals. Given the
efficacyofmiRNAsponges expressed fromstable chromo-
somal insertions, it seemed plausible that natural non-
coding RNAs might have evolved to sequence-specifically
sequester miRNAs. The first such endogenous sponge
RNA was discovered in plants and found to attenuate
a miRNA-mediated response to an environmental stress.
More recently, a viral non-coding RNA was observed to
sequester andpromote thedegradationof a cellularmiRNA
in infected primate cells. In this review we discuss the
potential andproven roles for endogenousmiRNAsponges
and consider somecriteria for screening candidate sponge
RNAs.
Introduction
microRNAs (miRNAs) arew21–23 nucleotide RNAs that are
derived from hairpin precursors and that associate with
Argonaute proteins to post-transcriptionally regulate target
genes, typically by binding to partially complementary
sequences in the 30 untranslated region (UTR). Over the
past few years miRNAs have been established as important
regulators of development and physiology in animals and
plants. Inhibition of miRNA activity by antisense oligonucle-
otides or antagomirs has been used to study their functions
but in many cases a more biological approach is preferable.
This approach is to block the activity of a specific miRNA of
interest using a competitive inhibitor called a miRNA sponge
or target mimic [1,2]. Sponge RNAs contain binding sites for
the miRNA either in a non-coding transcript or in the 30 UTR
of a reporter gene, and their expression is driven to a high
level by strong promoters such as U6 or CMV in mammalian
cells (Figure 1). Partial miRNA inhibition is achievable when
sponge RNAs are expressed from chromosomal transgene
insertions [1], and the use of lentiviral and retroviral sponge
vectors has enabled continuous miRNA inhibition in dividing
and non-dividing cells over long durations. These stable
sponge constructs have been used to probe the roles ofDepartment of Biology, Massachusetts Institute of Technology,
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E-mail: sharppa@mit.edumiRNAs in a variety of systems: in vitro differentiation of
neurons [3] and mesenchymal stem cells [4]; xenografts
of cancer cell lines [5,6]; and bone marrow reconstitutions
from hematopoietic stem/progenitor cells [7–9]. Germline
transgenic fruitflies have been shown to generate hypomor-
phicmiRNAphenotypeswhen sponge expression is induced
in a tissue-specific manner via the Gal4–UAS system [10].
Hypothetical Roles for Natural miRNA Sponges
Given the ability of stably integrated mRNA-based miRNA
sponges to specifically, and in some cases inducibly, inhibit
miRNA seed families, it seems reasonable to expect that
nature might also have invented this type of miRNA inhibitor.
There are further reasons to support this hypothesis. First,
miRNAs have been shown to be very stable [11], some with
in vivo half-lives of more than a week [12]; thus, it should
be more effective to induce a sponge RNA to sequence-
specifically sequester a miRNA than to sequence-specifi-
cally degrade the mature miRNA strand, which is encased
in an Argonaute protein complex. Sequestration by a target
mimic RNA would likely operate through seed specificity,
as appears to be the case for most target mRNAs, so in
this case an entire functional class of miRNA seed family
members would be inhibited. Finally, effective sponges
should be easy to evolve as they require only short stretches
of complementarity to miRNA seeds in regions of relatively
unstructured RNA. A sponge could contain sites for one
miRNA family or for a combination of miRNAs such that it
could serve as a specific rescue molecule for one or a few
target genes.
One can imagine several scenarios inwhich the expression
of a sponge RNA could add a layer of regulation to post-tran-
scriptional control ofmiRNA targets. During a developmental
transition or in response to a cellular stress, when amiRNA is
transcriptionally down-regulated, induction of a sponge RNA
could sharpen the loss of that miRNA activity over time
(Figure 2A). AmiRNA induced to respond to a transient stress
could be inhibited shortly thereafter by the accumulation of
a stress-induced sponge (Figure 2B). Alternatively, such
a stress-induced sponge could act as a quality controlmech-
anism, setting a threshold above which miRNA expression
must rise to adequately repress the expression of critical
target genes. A viral sponge RNA could inhibit a host miRNA
to change the infected cell’s gene expression program so as
to evade immune response or hijack cellular pathways to
promote viral propagation. A sponge RNA expressed in
a specific tissue could uncouple the activity of an intron-
derived miRNA from the expression of its host gene.
A tissue-specific sponge could also neutralize passenger
strand miRNA-containing ribonucleoprotein complexes
(miRNPs) to enhance the specificity of active miRNA
complexes (beyond what is determined by the thermody-
namic asymmetry of themiRNAduplex that normally controls
strand assembly), as has been donewith artificial sponges to
prevent passenger strand-mediated off-target effects from
short hairpin RNA (shRNA) vectors [13]. A sponge could be
constitutively expressed to fine-tune the activity of a miRNA
to a slightly lower level. In certain cellular contexts, such as
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Figure 1. Sponge RNAs compete with target
mRNAs for miRNA binding.
Sponge RNAs (in red) contain binding sites
(grey rectangles) for a miRNA of interest (grey
octagons). Left: in the presence of low sponge
expression, target mRNAs (in blue) are post-
transcriptionally repressed by the miRNA.
Right: in the presence of high sponge expres-
sion, target mRNAs are relieved of repression;
higher protein output (blue ovals) results.
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R859in neurons, spatially separated zones of
translation could experience major
consequences from local sequestration
of miRNA and the ensuing rescue of
expression of a small pool of messages.
Evidence for Natural miRNA Sponges
The first evidence for natural miRNA
sponges was discovered in plants [2].
The TPSI family of non-coding RNAs
(IPS1 and its paralog At4) are processed
as mRNAs but contain very short, poorly
conserved open reading frames. They
also contain in the 30 UTR a 23-nucleotide sequence that is
highly conserved among different plant species and that
can act as a single bulged binding site for miR-399. In fact,
the miRNA’s nucleotides 1–10 are perfectly paired in more
than 80% of IPS1 genes; there is additional strong,
conserved pairing to the miRNA’s 30 end. The mismatches
opposite nucleotides 10 and 11 protect the mRNA from
endonucleolytic cleavage by miR-399-loaded Argonautes.
While the TPSI RNAs are induced upon phosphate starva-
tion, miR-399 expression rises earlier, and the miR-399
target gene PHO2 is initially down-regulated [14]. Franco-
Zorrilla et al. [2] found that overexpressing IPS1 in the pres-
ence of miR-399 was able to rescue the level of PHO2mRNA
and thereby lower the shoot phosphate content. (Whether
the endogenous TPSI levels are sufficient to derepress
PHO2 to incur the same physiological response remains to
be shown.) As miR-399 and its sponge inhibitor are both
induced by phosphate stress, they appear to act in an inco-
herent manner to regulate PHO2 target expression. Depend-
ing on the relative production and turnover rates of the
miRNA and the sponge RNA, this type of regulatory architec-
ture could serve to generate a brief pulse of miRNA activity
followed by an attenuation period during which target
mRNA levels recover [14].
mRNAs that act as competitive inhibitors of regulatory
small RNAs (sRNAs) were also recently discovered in pro-
karyotes [15,16]. In this case a constitutively expressed,
long-lived sRNA binds to and is destabilized by a target
mimic RNA which is induced by chitobiose, a breakdown
product of chitin from the outer membrane [17]. What results
is derepression of a chitoporin gene whose message is nor-
mally degraded by the sRNA.
Sequence-specific miRNA destabilization was also
recently observed in an animal system. Marmoset T cells
transformed with the primate virus Herpesvirus saimiri (HSV)
contain abundant viral non-coding transcripts called
HSURs (H. saimiri U-rich RNAs). Highly conserved regions of
HSURs 1 and 2 have potential to base-pair with host miRNAs
miR-16, -27, and -142-3 p [18]. Psoralen cross-linkingexperiments and knockdown of specific HSURs confirm the
interaction of miR-27 with HSUR 1. Both miR-27 family
members, miR-27a and -27b, are post-transcriptionally
down-regulated inHSV-transformedcells in amanner depen-
dent on the presence of HSUR 1, and a pulse-chase assay
shows accelerated turnover of the miR-27a guide strand.
Additionally, protein expression of the miR-27 target gene
FOXO1 is up-regulated in the presence of HSUR 1. It is not
clear in which cellular compartment the HSUR interacts
with the mature miRNA; both miRNPs and HSURs might
shuttle between the nucleus and the cytoplasm. The mecha-
nism by which HSUR–miR-27 binding induces destruction
of the miRNA is also not yet known, but clearly involves
more than simple sequestration. Some users of artificial
miRNA sponges have reported substantial reduction in the
level of the inhibited miRNA [19–21]. In Drosophila and
in mammalian cells, target reporter sites with extensive
complementarity to the 30 end of the miRNA also appear to
stimulate miRNA turnover, by accelerating exonucleolytic
trimming of the miRNA [22]. This trimming phenomenon
may be taking place in the case of artificial target mimics
and perfectly complementary antisense oligonucleotide
inhibitors (‘antagomirs’) [22] and in the case of HSUR–
miR-27 interaction.
There are also hints that a viral miRNA sponge may be
produced in cells lytically infected with murine cytomegalo-
virus [23]. Upon infection, Buck et al. [23] observed rapid
post-transcriptional down-regulation of miR-27a and -27b,
in a manner dependent on RNA polymerase activity; higher
multiplicity of infection correlated with lower miR-27 levels.
A gain-of-function experiment showed that the miR-27
family suppresses viral replication, supporting the possibility
that inhibition of this miRNA family by a viral sponge RNA
could facilitate viral replication.
PTENP1 Pseudogene as a Source of Sponge Activity
Recently, a mammalian cellular non-coding RNA was pro-
posed as a miRNA sponge. PTENP1 is a pseudogene of
PTEN derived from retrotransposition and containing a
miRNA activity with sponge
miRNA activity without sponge
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Figure 2. Roles for natural sponges in regu-
lating miRNA activity.
(A) Rapid transitions: transcriptional down-
regulationof amiRNA is sharpenedby induction
of a sponge RNA that sequesters the lingering
mature miRNA. (B) Transient responses: a
stress-induced miRNA is allowed a pulse of
activity before being inhibited by accumulating
stress-induced sponge RNAs.
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protein [24]. The PTENP1 30 UTR is truncated but its proximal
region has 95% identity with the 30 UTRofPTEN and contains
sites for five of the miRNAs with conserved binding sites in
PTEN’s 30 UTR: miR-26, -17-5p/20, -21, -19, and -214. Of
these, miR-17-5 p/20 p and -19 (which are both naturally ex-
pressed from the sometimes oncogenic 17w92 cluster) are
able to repress both PTENP1 and PTEN RNA levels
to a similar degree (even though the PTEN 30 UTR con-
tains two additional conserved miR-19 sites). Retroviral
overexpression of the PTENP1 UTR derepresses PTEN in
a Dicer-dependent manner. More importantly, knockdown
of endogenous PTENP1 in prostate cancer cells results in
a decrease in PTEN mRNA and protein levels, and those of
the miR-17-5 p/20 target p21 and potentially other relevant
targets. This is accompanied by accelerated cell prolifera-
tion. PTENP1 and PTEN have correlated mRNA expression
in prostate tumor and normal prostate samples, and some
sporadic colon cancer samples are found to have PTENP1
copy number losses at the genomic level that correlate with
decreased PTEN mRNA expression. A similar correlation of
expression is found between KRAS and its pseudogene
KRAS1P.
Poliseno et al. [24] invoked a decoy activity for the pseu-
dogene RNA, suggesting it regulates PTEN expression by
competing for the same combination of miRNAs. However,
it seems unlikely that in the DU145 cells analyzed in the
study, in which the PTENP1 RNA is expressed at a much
lower level than the PTEN mRNA (w1%), the pseudogene
RNA could significantly modulate the level of PTEN and
other target genes through interaction with the miRNAs.
In some prostate cancer samples, the pseudogene is re-
ported to be expressed at approximately 10% the level of
the PTEN mRNA and in a few cases the two are approxi-
mately equal. It is unclear how RNAs from the pseudogene
expressed at these lower levels could successfully com-
pete for hundreds or thousands of miRNA molecules in
the presence of hundreds of target mRNAs. That said, it
is conceivable that an RNA regulator with special properties
such as those mentioned above for HSUR RNAs, perhaps
working by a catalytic miRNA-turnover mechanism, could
influence the expression of a target gene expressed at
a higher level. It is also conceivable that an RNA regulator
could be effective if the target genes it derepresses are
sensitive to subtle changes in protein level. PTEN isa haploinsufficient tumor suppressor
for which even a 20% decrease in
expression can promote cancer growth
[25]. In plants, in which target mRNAs
are dramatically inhibited by miRNAs
through endonucleolytic cleavage, the
target expression profile should be
more drastically shifted bythe introduction of a sponge RNA than in animals, in which
fine-tuning of targets by miRNAs may be the norm.
Potential Additional Natural miRNA Sponges
The plant TPSI RNAs, viral HSURs, and pseudogene RNAs
implicate classes of non-coding RNAs that could be further
investigated for potential miRNA sponges. There are several
other classes that should also be considered. Recently
genome-wide analysis of chromatin marks has uncovered
hundreds of large intergenic non-coding RNAs (lincRNAs)
[26]. Some of these transcripts act in the nucleus to regulate
gene expression by interaction with chromatin [27], while
others localize to the cytoplasm where they could interact
with mature miRNAs. It should be noted, however, that
having predominantly nuclear localization does not preclude
an RNA from being able to inhibit miRNA, as in the case of
HSUR 1 [18] or the U6 promoter-driven artificial miRNA
sponges [1]. There are also dozens of RNA-polymerase-III-
and II-generated mRNA-like non-coding RNAs of undeter-
mined function listed in non-coding RNA databases; some
have been detected at high levels in specific cell types or
under specific conditions [28]. Such RNAs may be tran-
scribed from intergenic promoters or from promoters within
30 UTRs. Another mechanism that can generate a 30 UTR
RNA was recently observed in mouse embryonic develop-
ment: an exon exclusion event causes the entire coding
region of the mRNA to be spliced out, leaving the untrans-
lated regions in a non-coding transcript [29]. Gene fusions
that are generated by translocation events can also create
new expression patterns for 30 UTRs or UTR fragments.
Can target mRNAs be miRNA sponges? It is possible that
some miRNA target genes whose repression is functionally
inconsequential evolved binding sites to act as sponges,
tuning miRNA availability to a precise level for the regulation
of a small number of targets whose repression does have
important phenotypic consequences [30]. Some observa-
tions of 30 UTR-mediated effects from the literature dating
before the discovery of miRNAs might now be appreciated
in light of a possible sponge mechanism. For example, phys-
iological levels of the 30 UTRs of alpha-cardiac actin, tropo-
myosin, and skeletal muscle troponin 1 were shown to boost
the expression of myogenin and promote differentiation of
myoblasts [31]; and the 30 UTRs of prohibitin [32] and
MAT1/PEA-15 [33] influenced proliferation in cancer cell
lines.
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sponge RNAs. As with target genes, the miRNA binding sites
aremore likely to be functional when located in regions of little
secondary structure (although effective decoys have been
reported in which the miRNA binding sites are presented
specifically in the unpaired sequences of short stem-loop
elements [34]), outside the footprint of ribosomes or RNA
binding proteins, andwhen they showsequenceconservation
among related species. There must be overlap in the expres-
sion and subcellular localization of the sponge RNA and the
miRNA(s) whose sites it contains in order for their molecular
encounters to occur. The higher the expression of the sponge
RNA, the more binding sites it contains, and the more exten-
sive the complementarity at the binding sites, the greater the
expected effect of sponge RNA on miRNA. When validating
a putative sponge, there must be demonstrable derepression
of target genes at physiological sponge RNA (and miRNA)
expression levels and thederepressiveeffectmustbeattribut-
able to the miRNA binding sites.Outlook
The discovery of natural transcripts that block miRNA
activity has revealed a new layer of post-transcriptional
regulationwithmany potential roles in the biology of animals,
plants, and viruses. A growing collection of non-coding
RNAs will be under investigation for their potential to interact
with miRNAs. Perhaps the search should also consider
competitive inhibitors for other classes of small RNAs,
such as endogenous small interfering RNAs (siRNAs) and
Piwi-interacting small RNAs (piRNAs).
Acknowledgments
We thank Mary Lindstrom for help preparing the figures and Graeme
Doran for helpful discussions. This work was supported by United
States Public Health Service grant R01-CA133404 from the National
Institutes of Health to P.A.S. and partially by Cancer Center Support
(core) grant P30-CA14051 from the National Cancer Institute.
References
1. Ebert, M.S., Neilson, J.R., and Sharp, P.A. (2007). MicroRNA sponges:
competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4,
721–726.
2. Franco-Zorrilla, J.M., Valli, A., Todesco, M., Mateos, I., Puga, M.I., Rubio-
Somoza, I., Leyva, A.,Weigel, D., Garcı´a, J.A., and Paz-Ares, J. (2007). Target
mimicry provides a new mechanism for regulation of microRNA activity.
Nat. Genet. 39, 1033–1037.
3. Barbato, C., Ruberti, F., Pieri, M., Vilardo, E., Costanzo, M., Ciotti, M.T.,
Zona, C., and Cogoni, C. (2010). MicroRNA-92 modulates K(+) Cl(-) co-
transporter KCC2 expression in cerebellar granule neurons. J. Neurochem.
113, 591–600.
4. Huang, J., Zhao, L., Xing, L., and Chen, D. (2010). MicroRNA-204 regulates
Runx2 protein expression and mesenchymal progenitor cell differentiation.
Stem Cells 28, 357–364.
5. Bonci, D., Coppola, V., Musumeci, M., Addario, A., Giuffrida, R., Memeo, L.,
D’Urso, L., Pagliuca, A., Biffoni, M., Labbaye, C., et al. (2008). The miR-15a-
miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic
activities. Nat. Med. 14, 1271–1277.
6. Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Sza´sz, A.M., Wang,
Z.C., Brock, J.E., Richardson, A.L., and Weinberg, R.A. (2009). A pleiotropi-
cally acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137,
1032–1046.
7. Gentner, B., Schira, G., Giustacchini, A., Amendola, M., Brown, B.D., Pon-
zoni, M., and Naldini, L. (2009). Stable knockdown of microRNA in vivo by
lentiviral vectors. Nat. Methods 6, 63–66.
8. Papapetrou, E.P., Korkola, J.E., and Sadelain, M. (2010). A genetic strategy
for single and combinatorial analysis ofmiRNA function inmammalian hema-
topoietic stem cells. Stem Cells 28, 287–296.
9. Starczynowski, D.T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R.,
Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R.A., et al. (2010). Identi-
fication of miR-145 and miR-146a as mediators of the 5q- syndrome pheno-
type. Nat. Med. 16, 49–58.10. Loya, C.M., Lu, C.S., Van Vactor, D., and Fulga, T.A. (2009). Transgenic micro-
RNA inhibition with spatiotemporal specificity in intact organisms. Nat.
Methods 6, 897–903.
11. Bail, S., Swerdel, M., Liu, H., Jiao, X., Goff, L.A., Hart, R.P., and Kiledjian, M.
(2010). Differential regulation of microRNA stability. RNA 16, 1032–1039.
12. van Rooij, E., Sutherland, L.B., Qi, X., Richardson, J.A., Hill, J., and Olson,
E.N. (2007). Control of stress-dependent cardiac growth and gene expres-
sion by a microRNA. Science 316, 575–579.
13. Mockenhaupt, S., Schurmann, N., and Grimm, D. (2010). Alleviation of
adverse shRNA off-targeting via vector-encoded passenger strand decoys.
Keystone symposium poster.
14. Chitwood, D.H., and Timmermans, M.C. (2007). Target mimics modulate
miRNAs. Nat. Genet. 39, 935–936.
15. Figueroa-Bossi, N., Valentini, M., Malleret, L., and Bossi, L. (2009). Caught at
its own game: regulatory small RNA inactivated by an inducible transcript
mimicking its target. Genes Dev. 23, 2004–2015.
16. Overgaard, M., Johansen, J., Møller-Jensen, J., and Valentin-Hansen, P.
(2009). Switching off small RNA regulation with trap-mRNA. Mol. Microbiol.
73, 790–800.
17. Mandin, P., and Gottesman, S. (2009). Regulating the regulator: an RNA
decoy acts as an OFF switch for the regulation of an sRNA. Genes Dev. 23,
1981–1985.
18. Cazalla, D., Yario, T., and Steitz, J. (2010). Down-regulation of a host micro-
RNA by a Herpesvirus saimiri noncoding RNA. Science 328, 1563–1566.
19. Rybak, A., Fuchs, H., Smirnova, L., Brandt, C., Pohl, E.E., Nitsch, R., and
Wulczyn, F.G. (2008). A feedback loop comprising lin-28 and let-7 controls
pre-let-7 maturation during neural stem-cell commitment. Nat. Cell Biol.
10, 987–993.
20. Sayed, D., Rane, S., Lypowy, J., He, M., Chen, I.Y., Vashistha, H., Yan, L.,
Malhotra, A., Vatner, D., and Abdellatif, M. (2008). MicroRNA-21 targets
Sprouty2 and promotes cellular outgrowths. Mol. Biol. Cell 19, 3272–3282.
21. Horie, T., Ono, K., Nishi, H., Iwanaga, Y., Nagao, K., Kinoshita, M., Kuwabara,
Y., Takanabe, R., Hasegawa, K., Kita, T., and Kimura, T. (2009). MicroRNA-
133 regulates the expression of GLUT4 by targeting KLF15 and is involved
in metabolic control in cardiac myocytes. Biochem. Biophys. Res. Commun.
389, 315–320.
22. Ameres, S.L., Horwich, M.D., Hung, J.H., Xu, J., Ghildiyal, M., Weng, Z., and
Zamore, P.D. (2010). Target RNA-directed trimming and tailing of small
silencing RNAs. Science 328, 1534–1539.
23. Buck, A.H., Perot, J., Chisholm,M.A., Kumar, D.S., Tuddenham, L., Cognat, V.,
Marcinowski, L., Do¨lken, L., and Pfeffer, S. (2010). Post-transcriptional regula-
tion of miR-27 in murine cytomegalovirus infection. RNA 16, 307–315.
24. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman,W.J., and Pandolfi,
P.P. (2010). A coding-independent function of gene and pseudogenemRNAs
regulates tumour biology. Nature 465, 1033–1038.
25. Alimonti,A.,Carracedo,A.,Clohessy, J.G., Trotman, L.C.,Nardella,C., Egia,A.,
Salmena, L., Sampieri, K., Haveman,W.J., Brogi, E., et al. (2010). Subtle varia-
tions in Pten dose determine cancer susceptibility. Nat. Genet. 42, 454–458.
26. Guttman,M.,Amit, I.,Garber,M., French,C., Lin,M.F., Feldser,D.,Huarte,M.,
Zuk, O., Carey, B.W., Cassady, J.P., et al. (2009). Chromatin signature reveals
over a thousand highly conserved large non-coding RNAs in mammals.
Nature 458, 223–227.
27. Khalil, A.M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D.,
Thomas, K., Presser, A., Bernstein, B.E., van Oudenaarden, A., et al. (2009).
Many human large intergenic noncoding RNAs associate with chromatin-
modifying complexes and affect gene expression. Proc. Natl Acad. Sci.
USA 28, 11667–11672.
28. Pang, K.C., Stephen, S., Engstro¨m, P.G., Tajul-Arifin, K., Chen, W., Wahles-
tedt, C., Lenhard, B., Hayashizaki, Y., and Mattick, J.S. (2005). RNAdb–
a comprehensive mammalian noncoding RNA database. Nucleic Acids
Res. 33, D125–130.
29. Kanadia, R.N., and Cepko, C.L. (2010). Alternative splicing produces high
levels of noncoding isoforms of bHLH transcription factors during develop-
ment. Genes Dev. 24, 229–234.
30. Seitz, H. (2009). Redefining microRNA targets. Curr. Biol. 19, 870–873.
31. Rastinejad, F., and Blau, H.M. (1993). Genetic complementation reveals
a novel regulatory role for 30 untranslated regions in growth and differentia-
tion. Cell 72, 903–917.
32. Jupe, E.R., Liu, X.T., Kiehlbauch, J.L., McClung, J.K., and Dell’Orco, R.T.
(1996). The 30 untranslated region of prohibitin and cellular immortalization.
Exp. Cell Res. 224, 128–135.
33. Tsukamoto, T., Yoo, J., Hwang, S.I., Guzman, R.C., Hirokawa, Y., Chou, Y.C.,
Olatunde, S., Huang, T., Bera, T.K., Yang, J., andNandi, S. (2000). Expression
of MAT1/PEA-15 mRNA isoforms during physiological and neoplastic
changes in the mouse mammary gland. Cancer Lett. 149, 105–113.
34. Haraguchi, T., Ozaki, Y., and Iba, H. (2009). Vectors expressing efficient RNA
decoys achieve the long-term suppression of specific microRNA activity in
mammalian cells. Nucleic Acids Res. 37, e43.
